417 related articles for article (PubMed ID: 31359615)
21. Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.
Barker B; Adams E; Wood E; Kerr T; DeBeck K; Dong H; Shoveller J; Montaner J; Milloy MJ
AIDS Behav; 2019 May; 23(5):1258-1266. PubMed ID: 30269233
[TBL] [Abstract][Full Text] [Related]
22. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.
Lee WK; Milloy MJS; Nosova E; Walsh J; Kerr T
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):103-109. PubMed ID: 30300214
[TBL] [Abstract][Full Text] [Related]
24. Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.
Culbert GJ; Waluyo A; Wang M; Putri TA; Bazazi AR; Altice FL
AIDS Behav; 2019 Aug; 23(8):2048-2058. PubMed ID: 30465106
[TBL] [Abstract][Full Text] [Related]
25. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
[TBL] [Abstract][Full Text] [Related]
26. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.
Bach P; Wood E; Dong H; Guillemi S; Kerr T; Montaner J; Milloy MJ
BMC Infect Dis; 2015 Nov; 15():537. PubMed ID: 26586238
[TBL] [Abstract][Full Text] [Related]
27. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.
Glenn MC; Sohler NL; Starrels JL; Maradiaga J; Jost JJ; Arnsten JH; Cunningham CO
Subst Abus; 2016; 37(3):387-391. PubMed ID: 26731299
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
[TBL] [Abstract][Full Text] [Related]
30. Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: A systematic review of trials and observational studies.
Mohd Salleh NA; Voon P; Karamouzian M; Milloy MJ; Richardson L
Drug Alcohol Depend; 2021 Jan; 218():108342. PubMed ID: 33097340
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting.
Joseph B; Wood E; Hayashi K; Kerr T; Barrios R; Parashar S; Richardson L; Dobrer S; Guillemi S; Montaner J; Milloy MJ
AIDS; 2016 Mar; 30(6):925-32. PubMed ID: 26636927
[TBL] [Abstract][Full Text] [Related]
33. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.
Nolan S; Hayashi K; Milloy MJ; Kerr T; Dong H; Lima VD; Lappalainen L; Montaner J; Wood E
Drug Alcohol Depend; 2015 Nov; 156():57-61. PubMed ID: 26455554
[TBL] [Abstract][Full Text] [Related]
34. Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.
Morozova O; Dvoryak S; Altice FL
Int J Drug Policy; 2013 Nov; 24(6):e91-8. PubMed ID: 24360402
[TBL] [Abstract][Full Text] [Related]
35. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
36. The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
Ti L; Socías ME; Wood E; Milloy MJ; Nosova E; DeBeck K; Kerr T; Hayashi K
PLoS One; 2018; 13(3):e0194162. PubMed ID: 29579073
[TBL] [Abstract][Full Text] [Related]
37. Client Acceptability for Integrating Antiretroviral Therapy in Methadone Maintenance Therapy Clinics in Sichuan, China.
Lin C; Li L; Cao X
Subst Use Misuse; 2017 Jan; 52(1):119-126. PubMed ID: 27682897
[TBL] [Abstract][Full Text] [Related]
38. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
[TBL] [Abstract][Full Text] [Related]
39. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
Ti L; Dong H; Kerr T; Turje RB; Parashar S; Min JE; Montaner J; Wood E; Milloy MJ
HIV Med; 2017 Sep; 18(8):580-586. PubMed ID: 28317290
[TBL] [Abstract][Full Text] [Related]
40. Assessing the Temporality Between Transitions onto Opioid Agonist Therapy and Engagement with Antiretroviral Therapy in a Cohort of HIV-Positive People Who Use Opioids Daily.
Mitra S; Grant C; Nolan S; Mohd Salleh NA; Milloy MJ; Richardson L
AIDS Behav; 2022 Jun; 26(6):1933-1942. PubMed ID: 34977956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
